In the present report, we provide evidence that resveratrol suppresses the TNF-β signaling pathway via the TNF-βR to decrease EMT, further highlighting its significant implications for inflammation-induced tumor promotion, particularly in CRC. Here, TNFRSF1B is linked to colorectal carcinoma.